Category: Politics and Regulation

Stanislaw Burzynski, pretending to do science.

The Texas Medical Board lets Stanislaw Burzynski off lightly: A cautionary tale of the failure of regulating medicine

After three years and countless twists and turns, the final decision by the Texas Medical Board on the sanctions to be imposed on Houston cancer quack Dr. Stanislaw Burzynski were announced on Friday. Sadly, they were not enough. The Burzynski saga should serve as a cautionary tale that the regulation of physicians and medicine is too lax, not too strict.

/ March 6, 2017
Chemotherapy Patient

Bills remove impediments to ill-advised state “right to try” laws, shield wrongdoers, and hide adverse events

Congressional bills will unleash state "right to try" laws, block terminally ill patients from redress for damages caused by negligent doctors and drug companies, and hide adverse drug events from the public.

/ March 2, 2017
Food_supplements

Bring on the Evidence: A new regulatory approach to CAM

Complementary and alternative medicine is popular, but it's poorly regulated, and most products lack good evidence of efficacy. A new approach proposed in Australia may help consumers make more informed, science-based health decisions.

/ February 23, 2017
Map_of_USA_showing_state_names

Turning chiropractors into primary care physicians via Legislative Alchemy

Via the magic of Legislative Alchemy, chiropractic lobbyists are trying to to convince state legislators to expand chiropractic scope of practice so they can rebrand as primary care physicians.

/ February 16, 2017
FTC

Regulating Health Care Products

How should we optimally regulate health care products to protect consumers? A conversation with the Acting Chairman of the FTC.

/ February 15, 2017
Donald Trump, Mike Pence, Andrew Wakefield, and Robert F. Kennedy, Jr.

In 2017, are antivaxers winning?

The election of Donald Trump as President has emboldened antivaxers, because they quite rightly sense that he is one of them. His inauguration as President, combined with other trends, have led observers to ask the question: Are antivaxers winning, or will 2017 be the year of the antivaxer?

/ February 13, 2017
Translational research and preclinical data

Donald Trump versus the FDA: Is the standard of evidence for drug approval actually too low rather than too high?

All of the candidates being considered by President Trump for FDA Commissioner believe that the FDA is too strict in its standards for approving new drugs. In a commentary in Nature last week, two bioethicists argued that, at least in terms of preclinical data, the standard of evidence is actually too low. Which is correct?

/ February 6, 2017
Three Stooges - Disorder in the Court

Board Disciplinary Actions. What Naturopaths Really Do Not Want You To Know

Disciplinary actions against ND's in Oregon by the Board. How to find them and what they are.

/ February 3, 2017
A_doctor_vaccinating_a_small_girl,_other_girls_with_loosened_Wellcome_V0016682 large

Battles over non-medical exemptions to vaccination festering in state legislatures

Bills to eliminate, as well as to add, non-medical exemptions to school vaccination requirements are pending in state legislatures. Some bills make harder to claim an exemption. Others discourage vaccination by requiring “misinformed consent" and weakening public health officials' ability to act.

/ February 2, 2017
Fire

Flame Retardants Have Ignited a Flaming Controversy

Flame retardants are controversial: proponents say they reduce fire damage and save lives; critics say they don't work, are poisoning our environment, and should be banned.

/ January 24, 2017